{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:00:17Z","timestamp":1793170817896,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","giejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.gie.2024.12.019","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T15:42:48Z","timestamp":1734363768000},"page":"762-771.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis"],"prefix":"10.1016","volume":"101","author":[{"given":"Muhammad Usman","family":"Baig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Lahooti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate Elise","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Rangwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zane","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srihari","family":"Mahadev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Newberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hanscom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Anca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison Raye","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Leslie","family":"Carr-Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3235-6904","authenticated-orcid":false,"given":"Reem Z.","family":"Sharaiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gie.2024.12.019_bib1","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s12325-021-01710-0","article-title":"Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists","volume":"38","author":"Ard","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.gie.2024.12.019_bib2","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gie.2024.12.019_bib3","article-title":"Anesthesia considerations for a patient on semaglutide and delayed gastric emptying","volume":"15","author":"Fujino","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.gie.2024.12.019_bib4","unstructured":"Joshi GP, Abdelmalak BB, Weigel WA, et\u00a0al. American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. Available at: https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative. Accessed June 29, 2023."},{"key":"10.1016\/j.gie.2024.12.019_bib5","unstructured":"AASLD\/ACG\/AGA\/ASGE\/NASPGHAN multisociety statement. No data to support stopping GLP-1 agonists prior to elective endoscopy. Available at: https:\/\/gastro.org\/news\/gi-multi-society-statement-regarding-glp-1-agonists-and-endoscopy\/. Accessed August 11, 2023."},{"key":"10.1016\/j.gie.2024.12.019_bib6","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.gie.2024.12.019_bib7","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.gie.2024.12.019_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.gie.2024.12.019_bib9","unstructured":"Wells G, Shea B, O\u2019Connell D, et\u00a0al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis.\u00a02000. Available at: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed July 20, 2024."},{"key":"10.1016\/j.gie.2024.12.019_bib10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/10600280211055804","article-title":"Impact of glucagon-like peptide-1 receptor agonists (GLP-1RA) on food content during esophagogastroduodenoscopy (EGD)","volume":"56","author":"Stark","year":"2022","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.gie.2024.12.019_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira","year":"2023","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.gie.2024.12.019_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/jdi.14005","article-title":"Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy","volume":"14","author":"Kobori","year":"2023","journal-title":"J\u00a0Diabetes Invest"},{"key":"10.1016\/j.gie.2024.12.019_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2024.03.015","article-title":"Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with glucagon-like peptide 1 receptor agonist use","volume":"167","author":"Yeo","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2024.12.019_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.14309\/ajg.0000000000002777","article-title":"Glucagon-like peptide-1 receptor agonists increase solid gastric residue rates on upper endoscopy especially in patients with complicated diabetes: a case-control study","volume":"119","author":"Garza","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2024.12.019_bib15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"key":"10.1016\/j.gie.2024.12.019_bib16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s12630-024-02719-z","article-title":"Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study","volume":"71","author":"Wu","year":"2024","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.gie.2024.12.019_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.gie.2024.04.2900","article-title":"Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and non-diabetic patients","volume":"100","author":"Nadeem","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2024.12.019_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cgh.2024.04.038","article-title":"Glucagon-like peptide-1 receptor agonists do not increase aspiration during upper endoscopy in patients with diabetes","volume":"23","author":"Barlowe","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl","key":"10.1016\/j.gie.2024.12.019_bib19","article-title":"The impact of semaglutide on retained gastric contents during endoscopy","volume":"166","author":"Gu","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2024.12.019_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)03207-4","article-title":"Clinical impact of GLP-1RA on endoscopy: a retrospective cohort study in endoscopy patients","volume":"166","author":"Karlson","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2024.12.019_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)03194-9","article-title":"Increased risk of residual gastric content in patients on GLP-1 agonists undergoing esophagogastroduodenoscopy","volume":"166","author":"Meluban","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2024.12.019_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)01939-5","article-title":"Glucagon-like-peptide-1 receptor agonists (GLP-1RA): impact on outpatient upper endoscopy procedure quality [abstract]","volume":"166","author":"Peng","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2024.12.019_bib23","doi-asserted-by":"crossref","first-page":"AB230","DOI":"10.1016\/j.gie.2024.04.1085","article-title":"Endoscopic gastric food retention rates for GLP-1RA users can be potentially mitigated by pre-colonoscopy fasting protocols in a propensity-matched cohort study [abstract]","volume":"99","author":"Rizvi","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2024.12.019_bib24","article-title":"Incidence of aspiration pneumonitis and emergent intubation in patients on glucagon-like peptide-1 inhibitors undergoing upper endoscopy and colonoscopy: a comparative study","volume":"99","author":"Kumar","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2024.12.019_bib25","doi-asserted-by":"crossref","first-page":"AB261","DOI":"10.1016\/j.gie.2024.04.1137","article-title":"The impact of glucagon-like peptide- 1 receptor agonists use prior to esophagogastroduodenoscopy","volume":"99","author":"Ayoub","year":"2024","journal-title":"Gastrointestinal Endosc"},{"key":"10.1016\/j.gie.2024.12.019_bib26","doi-asserted-by":"crossref","first-page":"AB387","DOI":"10.1016\/j.gie.2024.04.1307","article-title":"Low rates of gastric food retention during endoscopy in patients on glucagon-like-peptide-1 receptor agonists at a large academic center","volume":"99","author":"Dev","year":"2024","journal-title":"Gastrointestinal Endosc"},{"key":"10.1016\/j.gie.2024.12.019_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)01242-3","article-title":"Real-world impact of GLP-1 receptor agonists on endoscopic patient outcomes in an ambulatory setting. A retrospective study at a large tertiary center","volume":"166","author":"Gonzaga","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2024.12.019_bib28","doi-asserted-by":"crossref","first-page":"AB279","DOI":"10.1016\/j.gie.2024.04.1171","article-title":"GLP-1 receptor agonist effect on retained gastric contents on EGD: a quality improvement study","volume":"99","author":"Hernandez","year":"2024","journal-title":"Gastrointestinal Endosc"},{"key":"10.1016\/j.gie.2024.12.019_bib29","doi-asserted-by":"crossref","first-page":"AB366","DOI":"10.1016\/j.gie.2024.04.1269","article-title":"Semaglutide is an independent risk factor for retained gastric contents and recommendation for repeat upper endoscopy: results from a real-world population cohort study","volume":"99","author":"Korlipara","year":"2024","journal-title":"Gastrointestinal Endosc"},{"key":"10.1016\/j.gie.2024.12.019_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2024.04.2871","article-title":"Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use predicts retained gastric contents but not increased risk of major adverse anesthesia-related events during upper endoscopy [abstract]","volume":"99","author":"Markley","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gie.2024.12.019_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)03196-2","article-title":"Colonoscopy preparation may mitigate food retention in patients using glucagon-like peptide-1 receptor agonists who are undergoing upper endoscopy","volume":"166","author":"Nasser","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gie.2024.12.019_bib32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.gie.2024.05.012","article-title":"Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD","volume":"100","author":"Chapman","year":"2024","journal-title":"Gastrointestinal Endosc"},{"key":"10.1016\/j.gie.2024.12.019_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/ALN.0000000000001452","volume":"126","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.gie.2024.12.019_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/5584_2020_496","article-title":"Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity","volume":"1307","author":"Maselli","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.gie.2024.12.019_bib35","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000559","article-title":"Practice patterns and outcomes of patients with retained gastric food content encountered during endoscopy","volume":"14","author":"Lin","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gie.2024.12.019_bib36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.14309\/ajg.0000000000002820","article-title":"Quantified metrics of gastric emptying delay by glucagon-like peptide-1 agonists: a systematic review and meta-analysis with insights for periprocedural management","volume":"119","author":"Hiramoto","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gie.2024.12.019_bib37","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/dom.13633","article-title":"Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes","volume":"21","author":"Jones","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.gie.2024.12.019_bib38","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2337\/diabetes.54.7.2212","article-title":"Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects","volume":"54","author":"Meier","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.gie.2024.12.019_bib39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cgh.2024.07.021","article-title":"Effects of glucagon-like peptide-1 receptor agonists on upper gastrointestinal endoscopy: a meta-analysis","volume":"23","author":"Facciorusso","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gie.2024.12.019_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.gie.2024.12.019_bib41","first-page":"195","article-title":"Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial","volume":"108","author":"Clark","year":"2020","journal-title":"J\u00a0Med Libr Assoc"}],"container-title":["Gastrointestinal Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510724037945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510724037945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T16:09:53Z","timestamp":1747843793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016510724037945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0016510724037945"],"URL":"https:\/\/doi.org\/10.1016\/j.gie.2024.12.019","relation":{},"ISSN":["0016-5107"],"issn-type":[{"value":"0016-5107","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric contents and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gie.2024.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Society for Gastrointestinal Endoscopy","name":"copyright","label":"Copyright"}]}}